Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Tolerability of Staccato Alprazolam in Stereotypical Prolonged Seizures
NCT05076617Phase 3Enrolling by invitation
- Sponsor
- UCB
- Start
- Feb 2022
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of alprazolam in status epilepticus (SE), sponsored by UCB. Started Feb 2022; status: enrolling by invitation.
02
Drugs
alprazolam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT05076617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076617.